{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:20:26Z","timestamp":1791501626004,"version":"4.3.4"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,2,1]]},"DOI":"10.2169\/internalmedicine.4748-20","type":"journal-article","created":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T22:06:59Z","timestamp":1612130819000},"page":"337-343","source":"Crossref","is-referenced-by-count":16,"title":["Establishing Efficient Systems through Electronic Medical Records to Promote Intra-hospital Referrals of Hepatitis Virus Carriers to Hepatology Specialists: A Multicenter Questionnaire-based Survey of 1,281 Healthcare Professionals"],"prefix":"10.2169","volume":"60","author":[{"given":"Isao","family":"Hidaka","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yamaguchi University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Enomoto","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Osaka City University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syuichi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Shimane University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Suetsugu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology\/Internal Medicine, Gifu University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomitsu","family":"Matono","sequence":"additional","affiliation":[{"name":"Department of Multidisciplinary Internal Medicine, Tottori University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoaki","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Aichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Inoue","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Tohoku University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Horino","sequence":"additional","affiliation":[{"name":"Kochi Medical School Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuteru","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Sendai Kousei Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Sakaida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yamaguchi University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Korenaga","sequence":"additional","affiliation":[{"name":"Hepatitis Information Center, Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. World Health Organization. Hepatitis [Internet]. [cited 2020 Feb 9]. Available from: https:\/\/www.who.int\/hepatitis\/about\/en\/."},{"key":"2","unstructured":"2. Tanaka J, Akita T, Ko K, Miura Y, Satake M; Epidemiological Research Group on Viral Hepatitis and its Long-term Course Ministry of Health, Labour and Welfare of Japan. Countermeasures against viral hepatitis B and C in Japan: an epidemiological point of view. Hepatol Res 49: 990-1002, 2019."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol 67: 370-398, 2017.","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2018. J Hepatol 69: 461-511, 2018.","DOI":"10.1016\/j.jhep.2018.03.026"},{"key":"5","unstructured":"5. Tateishi R, Uchino K, Fujiwara N, et al. A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update. J Gastroenterol 54: 367-376, 2019."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Liaw YF, Sung JJY, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351: 1521-1531, 2004.","DOI":"10.1056\/NEJMoa033364"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Hosaka T, Suzuki F, Kobayashi M, et al. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology 58: 98-107, 2013.","DOI":"10.1002\/hep.26180"},{"key":"8","unstructured":"8. Waziry R, Hajarizadeh B, Grebely J, et al. Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression. J Hepatol 67: 1204-1212, 2017."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Mitchell AE, Colvin HM, Beasley RP. Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology 51: 729-733, 2010.","DOI":"10.1002\/hep.23561"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Furukawa N, Kawaguchi Y, Oeda S, et al. Current management practices for HBs antigen or anti-HCV antibody positive individuals in non-hepatology departments at a university hospital. Kanzo 54: 307-316, 2013 (in Japanese with English abstract).","DOI":"10.2957\/kanzo.54.307"},{"key":"11","unstructured":"11. Oza N, Isoda H, Ono T, Kanto T. Current activities and future directions of comprehensive hepatitis control measures in Japan: the supportive role of the Hepatitis Information Center in building a solid foundation. Hepatol Res 47: 487-496, 2017."},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Shimomura Y, Ikeda F, Nouso K, et al. Introduction of management system of positive test results for HBV and HCV infection in electronic medical chart. Kanzo 56: 137-143, 2015 (in Japanese with English abstract).","DOI":"10.2957\/kanzo.56.137"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Uchida-Kobayashi S, Enomoto M, Fujii H, et al. Promotion of intra-hospital referral of hepatitis B and C virus carriers to hepatology specialists by electronic medical record-based alert system: a case study at a university hospital. Kanzo 57: 7-16, 2016 (in Japanese with English abstract).","DOI":"10.2957\/kanzo.57.7"},{"key":"14","unstructured":"14. Fujii H, Yamaguchi S, Kurai O, et al. Putting "sticky notes" on the electronic medical record to promote intra-hospital referral of hepatitis B and hepatitis C virus-positive patients to hepatology specialists: an expoloratory study. BMC Infect Dis 16: 410, 2016."},{"key":"15","unstructured":"15. The Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2: 161-176, 2017."},{"key":"16","unstructured":"16. Kabiri M, Jazwinski AB, Roberts MS, Schaefer AJ, Chhatwal J. The changing burden of hepatitis C virus infection in the United States: model-based predictions. Ann Intern Med 161: 170-180, 2014."},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Kanwal F, Kramer J, Asch SM, Chayanupatkul M, Cao Y, El-Serag HB. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents. Gastroenterology 153: 996-1005.e1, 2017.","DOI":"10.1053\/j.gastro.2017.06.012"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Konerman MA, Thomson M, Gray K, et al. Impact of an electronic health record alert in primary care on increasing hepatitis c screening and curative treatment for baby boomers. Hepatology 66: 1805-1813, 2017.","DOI":"10.1002\/hep.29362"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Okubo T, Atsukawa M, Tsubota A, et al. Epidemiological survey of patients with hemodialysis complicated by hepatitis C in Japan. Ther Apher Dial 23: 44-48, 2019.","DOI":"10.1111\/1744-9987.12747"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Inoue T, Urano S, Inoue I, Korenaga M, Tanaka Y. Recommendation of medical consultation and\/or treatment by pharmacists to patients with chronic hepatitis C who visited health insurance pharmacies. Kanzo 58: 639-642, 2017 (in Japanese with English abstract).","DOI":"10.2957\/kanzo.58.639"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/3\/60_4748-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T03:41:18Z","timestamp":1670989278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/3\/60_4748-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4748-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}